Edward MD - Femasys Chief Officer

FEMY Stock  USD 0.90  0.09  11.11%   

Insider

Edward MD is Chief Officer of Femasys
Age 61
Address 3950 Johns Creek Court, Suwanee, GA, United States, 30024
Phone770 500 3910
Webhttps://www.femasys.com

Femasys Management Efficiency

The company has return on total asset (ROA) of (0.6569) % which means that it has lost $0.6569 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.3987) %, meaning that it created substantial loss on money invested by shareholders. Femasys' management efficiency ratios could be used to measure how well Femasys manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.6 in 2025. Return On Capital Employed is likely to rise to -4.37 in 2025. At this time, Femasys' Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 18.4 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 4.2 M in 2025.
Femasys currently holds 7.44 M in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Femasys has a current ratio of 10.68, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Femasys' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Keisha HarcumMilestone Scientific
N/A
Kean LokeTop Glove
N/A
Richard ForkeyPrecision Optics,
85
Robert DeLucciaAcurx Pharmaceuticals LLC
79
MAICSA FCISTop Glove
65
Hooi CheohTop Glove
50
Joseph ForkeyPrecision Optics,
57
Vashone ThomasNephros
N/A
Richard CyrPrecision Optics,
N/A
Daniel HabheggerPrecision Optics,
54
Guan OngTop Glove
N/A
CPA CPAAcurx Pharmaceuticals LLC
58
Yong NgTop Glove
37
John HargravesPrecision Optics,
N/A
Joleen TurnerNephros
N/A
WeiAnn VoonTop Glove
N/A
Donald MajorPrecision Optics,
63
Femasys Inc., a biomedical company, focuses on womens healthcare market in the United States. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia. Femasys operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 27 people. Femasys (FEMY) is traded on NASDAQ Exchange in USA. It is located in 3950 Johns Creek Court, Suwanee, GA, United States, 30024 and employs 69 people. Femasys is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Femasys Leadership Team

Elected by the shareholders, the Femasys' board of directors comprises two types of representatives: Femasys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Femasys. The board's role is to monitor Femasys' management team and ensure that shareholders' interests are well served. Femasys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Femasys' outside directors are responsible for providing unbiased perspectives on the board's policies.
Steven Damon, VP Devel
James MD, Chief Officer
Richard Spector, Chief Officer
Kelley Nicholas, Chief Officer
Kathy LeeSepsick, President, Founder
Christine Thomas, Senior Affairs
Dov Elefant, Chief Officer
Todd MBA, Chief Advisor
Daniel Currie, Senior COO
MS MD, Chief Advisor
Benjamin Dings, Vice Sales
Kathy MBA, President Founder
Edward MD, Chief Officer
Mary JD, Vice Property
Sue Owens, Vice Sales
Naomi Phaneuf, Vice Marketing

Femasys Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Femasys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Femasys Stock Analysis

When running Femasys' price analysis, check to measure Femasys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Femasys is operating at the current time. Most of Femasys' value examination focuses on studying past and present price action to predict the probability of Femasys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Femasys' price. Additionally, you may evaluate how the addition of Femasys to your portfolios can decrease your overall portfolio volatility.